Search for: "Pfizer, Inc." Results 1141 - 1160 of 1,512
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Feb 2016, 4:00 am by Alan Macek
Wyeth and Pfizer Canada Inc., 2011 FC 1169 at 34 reversed on other grounds 2012 FCA 141, Louis Vuitton Malletier S.A. v. [read post]
27 May 2009, 4:09 am
Pfizer Inc. more than doubled its spending on lobbying in the period to $6.1 million.Earlier this month, drug makers joined doctors, insurers and hospitals in a pledge to rein in health-care cost increases by $2 trillion over the next decade. [read post]
3 Aug 2011, 3:31 am by Marie Louise
Paddock (Orange Book Blog) (Holman’s Biotech IP Blog) Cetrorelix – UK: Non-payment of Cetrorelix fee on time fatal for SPC: Case BLO/252/11 The Administrators of the Tulane Education Fund (The SPC Blog) Detrol (Tolterodine tartrate) – US: Pfizer files patent infringement complaint against Torrent Pharma in response to Para IV certification filing (Patent Docs) Galantamine – EU: CJEU ruling in Case C-427/09 Generics (UK) Ltd v Synaptech (The SPC Blog) (EPLAW)… [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan (Fluconazole)… [read post]
26 Jan 2015, 4:00 am by Kimberly A. Kralowec
Pfizer, Inc. (2010) 49 Cal.4th 758 in which the Supreme Court held retail pharmacies had standing to assert UCL claims against pharmaceutical companies that had allegedly engaged in price fixing even though the retail pharmacies were able to pass on any overcharges to their customers. [read post]
6 Nov 2015, 6:58 am
 The patent belongs Warner-Lambert, a company that was acquired by Pfizer in 2000. [read post]
23 Oct 2008, 10:31 am
"        According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped selling...last year. [read post]
27 Jul 2012, 12:40 pm by Bexis
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]